HMGCR and glioblastoma: According to Bhat et al. [49], the combination of the dopamine receptor antagonist quetiapine and the HMGCR inhibitor atorvastatin, along with irradiation, significantly extended survival in mice bearing orthotopic patient-derived glioblastoma xenografts.